These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29946054)

  • 1. Plasma PCSK9 correlates with apoB-48-containing triglyceride-rich lipoprotein production in men with insulin resistance.
    Drouin-Chartier JP; Tremblay AJ; Hogue JC; Lemelin V; Lamarche B; Couture P
    J Lipid Res; 2018 Aug; 59(8):1501-1509. PubMed ID: 29946054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism.
    Chan DC; Watts GF; Somaratne R; Wasserman SM; Scott R; Barrett PHR
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1644-1655. PubMed ID: 29880491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state.
    Chan DC; Wong AT; Pang J; Barrett PH; Watts GF
    Clin Sci (Lond); 2015 Mar; 128(6):379-85. PubMed ID: 25291660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential associations between plasma concentrations of insulin and glucose and intestinal expression of key genes involved in chylomicron metabolism.
    Drouin-Chartier JP; Tremblay AJ; Lemelin V; Lamarche B; Couture P
    Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G177-G184. PubMed ID: 29698057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein levels are inversely correlated with the apolipoprotein B-48-containing triglyceride-rich lipoprotein production rate in insulin resistant men.
    Drouin-Chartier JP; Tremblay AJ; Hogue JC; Leclerc M; Labonté MÈ; Marin J; Lamarche B; Couture P
    Metabolism; 2017 Mar; 68():163-172. PubMed ID: 28183448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms.
    Rashid S; Tavori H; Brown PE; Linton MF; He J; Giunzioni I; Fazio S
    Circulation; 2014 Jul; 130(5):431-41. PubMed ID: 25070550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes.
    Hogue JC; Lamarche B; Tremblay AJ; Bergeron J; Gagné C; Couture P
    J Lipid Res; 2007 Jun; 48(6):1336-42. PubMed ID: 17337758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key intestinal genes involved in lipoprotein metabolism are downregulated in dyslipidemic men with insulin resistance.
    Couture P; Tremblay AJ; Kelly I; Lemelin V; Droit A; Lamarche B
    J Lipid Res; 2014 Jan; 55(1):128-37. PubMed ID: 24142110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The apoB-to-PCSK9 ratio: A new index for metabolic risk in humans.
    Wassef H; Bissonnette S; Saint-Pierre N; Lamantia V; Cyr Y; Chrétien M; Faraj M
    J Clin Lipidol; 2015; 9(5):664-75. PubMed ID: 26350813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels.
    Drouin-Chartier JP; Hogue JC; Tremblay AJ; Bergeron J; Lamarche B; Couture P
    Lipids Health Dis; 2017 Jun; 16(1):119. PubMed ID: 28619117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects.
    Taskinen MR; Björnson E; Andersson L; Kahri J; Porthan K; Matikainen N; Söderlund S; Pietiläinen K; Hakkarainen A; Lundbom N; Nilsson R; Ståhlman M; Adiels M; Parini P; Packard C; Borén J
    J Clin Lipidol; 2020; 14(1):77-87. PubMed ID: 31917184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans.
    Duez H; Lamarche B; Valéro R; Pavlic M; Proctor S; Xiao C; Szeto L; Patterson BW; Lewis GF
    Circulation; 2008 May; 117(18):2369-76. PubMed ID: 18443237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
    Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia.
    Afanasieva OI; Ezhov MV; Razova OA; Afanasieva MI; Utkina EA; Pokrovsky SN
    Atherosclerosis; 2018 Oct; 277():477-482. PubMed ID: 30270088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation between the insulin-sensitizing effect of rosiglitazone and its effect on hepatic and intestinal lipoprotein production.
    Duez H; Lamarche B; Uffelman KD; Valéro R; Szeto L; Lemieux S; Cohn JS; Lewis GF
    J Clin Endocrinol Metab; 2008 May; 93(5):1722-9. PubMed ID: 18285418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism in obese, nondiabetic humans.
    Padilla N; Maraninchi M; Béliard S; Berthet B; Nogueira JP; Wolff E; Nicolay A; Bégu A; Dubois N; Grangeot R; Mattei C; Vialettes B; Xiao C; Lewis GF; Valéro R
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2330-7. PubMed ID: 25104797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitution of dietary ω-6 polyunsaturated fatty acids for saturated fatty acids decreases LDL apolipoprotein B-100 production rate in men with dyslipidemia associated with insulin resistance: a randomized controlled trial.
    Drouin-Chartier JP; Tremblay AJ; Lépine MC; Lemelin V; Lamarche B; Couture P
    Am J Clin Nutr; 2018 Jan; 107(1):26-34. PubMed ID: 29381796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary medium-chain triglyceride supplementation has no effect on apolipoprotein B-48 and apolipoprotein B-100 kinetics in insulin-resistant men.
    Tremblay AJ; Lamarche B; Labonté MÈ; Lépine MC; Lemelin V; Couture P
    Am J Clin Nutr; 2014 Jan; 99(1):54-61. PubMed ID: 24172309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans.
    Duez H; Lamarche B; Uffelman KD; Valero R; Cohn JS; Lewis GF
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1357-63. PubMed ID: 16614317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Independently Associated with Insulin Resistance, Triglycerides, Lipoprotein(a) Levels but not Low-Density Lipoprotein Cholesterol Levels in a General Population.
    Hamamura H; Adachi H; Enomoto M; Fukami A; Nakamura S; Nohara Y; Morikawa N; Sakaue A; Toyomasu K; Yamamoto M; Fukumoto Y
    J Atheroscler Thromb; 2021 Apr; 28(4):329-337. PubMed ID: 32624555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.